M J Piccart

Use of tumour markers in monitoring the course of ovarian cancer.

S M Bentzen, M. Piccart, G. Rustin, 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

A randomized double-blind multicenter phase III study of fixed-dose single-administration pegfilgrastim versus daily filgrastim in patients receiving myelosuppressive chemotherapy.

M. Piccart, J. Baselga, P. Gascón, 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

Proliferative markers as prognostic and predictive tools in early breast cancer: where are we now?

C Sotiriou, C. Sotiriou, D. Larsimont, 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial.

S Michiels, C Desmedt, C Sotiriou, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS).

M. Piccart, U. Dafni, E. D. de Vries, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

Bortezomib/docetaxel combination therapy in patients with anthracycline-pretreated advanced/metastatic breast cancer: a phase I/II dose-escalation study

M. Piccart, J. Baselga, F. Cardoso, 2008, British Journal of Cancer.

ESMO-Magnitude of Clinical Benefit Scale version 1.1

J Bogaerts, M. Piccart, U. Dafni, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Updated analysis of the NCIC CTG MA.17 randomized placebo (P) controlled trial of letrozole (L) after five years of tamoxifen in postmenopausal women with early stage breast cancer.

J L Pater, M. Piccart, S. Martino, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The impact of chemotherapy dose density and dose intensity on breast cancer outcome: what have we learned?

L Biganzoli, M. Piccart, A. Di Leo, 2000, European journal of cancer.